DK0720595T3 - Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation - Google Patents

Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation

Info

Publication number
DK0720595T3
DK0720595T3 DK94928427T DK94928427T DK0720595T3 DK 0720595 T3 DK0720595 T3 DK 0720595T3 DK 94928427 T DK94928427 T DK 94928427T DK 94928427 T DK94928427 T DK 94928427T DK 0720595 T3 DK0720595 T3 DK 0720595T3
Authority
DK
Denmark
Prior art keywords
pct
enantiomer
solution
sec
mother liquors
Prior art date
Application number
DK94928427T
Other languages
Danish (da)
English (en)
Inventor
Roger Bouaziz
Gerard Coquerel
Marie-Noelle Petit
Original Assignee
Univ Rouen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rouen filed Critical Univ Rouen
Application granted granted Critical
Publication of DK0720595T3 publication Critical patent/DK0720595T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/78Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by condensation or crystallisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
DK94928427T 1993-09-23 1994-09-22 Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation DK0720595T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9311354A FR2710337B1 (fr) 1993-09-23 1993-09-23 Procédé de dédoublement de deux antipodes optiques par entraînement polythermique programmé et autoensemencé.
PCT/FR1994/001107 WO1995008522A1 (fr) 1993-09-23 1994-09-22 Procede de dedoublement de deux antipodes optiques par cristallisation

Publications (1)

Publication Number Publication Date
DK0720595T3 true DK0720595T3 (da) 1999-08-23

Family

ID=9451175

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94928427T DK0720595T3 (da) 1993-09-23 1994-09-22 Fremgangsmåde til adskillelse af to optiske antipoder ved krystallisation

Country Status (9)

Country Link
US (1) US6022409A (de)
EP (1) EP0720595B1 (de)
JP (1) JP3647862B2 (de)
AT (1) ATE174889T1 (de)
DE (1) DE69415545T2 (de)
DK (1) DK0720595T3 (de)
ES (1) ES2128584T3 (de)
FR (1) FR2710337B1 (de)
WO (1) WO1995008522A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008563D0 (en) * 2000-04-07 2000-05-24 Cambridge Discovery Chemistry Investigating different physical and/or chemical forms of materials
FR2849029B1 (fr) * 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7501514B1 (en) 2003-10-15 2009-03-10 Shire Biochem, Inc. Enantiomeric resolution of 2-substituted 4-substituted 1,3-oxathiolanes nucleosides
DE102005039501B4 (de) * 2005-08-20 2013-09-12 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Trennung verbindungsbildender chiraler Systeme
US20080070890A1 (en) * 2006-09-15 2008-03-20 Burnett Duane A Spirocyclic Azetidinone Compounds and Methods of Use Thereof
MX2009002921A (es) * 2006-09-15 2009-04-01 Schering Corp Derivados de azetidinona para el tratamiento de trastornos del metabolismo lipidico.
FR2909380B1 (fr) 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
EP2334620B1 (de) 2008-09-05 2018-09-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur enantioselektiven trennung chiraler systeme mit verbindungsbildung unter anwendung von zwei aufeinanderfolgenden kristallisationsschritten
WO2010026439A1 (en) * 2008-09-05 2010-03-11 Shire Biochem Inc. Enantiomeric resolution of 2,4-disubstituted 1,3-oxathiolane nucleosides
ES2436633T3 (es) * 2009-03-26 2014-01-03 Poxel Procedimiento para la separación de enantiómeros de dihidro-1,3,5-triazinas racémicas por cristalización preferencial
EP2292306B1 (de) 2009-09-02 2013-05-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zum Trennen von racemischen verbindungsbildenden chiralen Substanzen durch ein zyklisches Kristallisationsverfahren und eine Kristallisationsvorrichtung
FR2954310B1 (fr) * 2009-12-18 2014-07-25 Univ Rouen Procede de dedoublement d'enantiomeres par evapocristallisation preferentielle
FR3054218B1 (fr) * 2016-07-22 2020-03-06 Universite De Rouen Procede de dedoublement de sels de baclofene
WO2020191163A1 (en) 2019-03-20 2020-09-24 Regeneron Pharmaceuticals, Inc. Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (scap) inhibitors
JP7574206B2 (ja) 2019-03-20 2024-10-28 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ステロール調節エレメント結合転写因子1(srebf1)阻害剤による上昇した脂質レベルの治療
WO2025049558A1 (en) 2023-08-29 2025-03-06 Regeneron Pharmaceuticals, Inc. Treatment of liver disease or metabolic disorder with folliculin interacting protein 1 (fnip1) inhibitors and/or folliculin (flcn) inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1456627A (fr) * 1964-07-24 1966-07-08 Asahi Chemical Ind Perfectionnements aux procédés pour la résolution de l'acide glutamique racémique et de ses sels
GB1197809A (en) * 1968-02-13 1970-07-08 Inst Noguchi Method for Continuous Optical Resolution of Organic Racemates.

Also Published As

Publication number Publication date
WO1995008522A1 (fr) 1995-03-30
EP0720595A1 (de) 1996-07-10
ATE174889T1 (de) 1999-01-15
JP3647862B2 (ja) 2005-05-18
FR2710337B1 (fr) 1995-12-08
US6022409A (en) 2000-02-08
JPH09506861A (ja) 1997-07-08
EP0720595B1 (de) 1998-12-23
ES2128584T3 (es) 1999-05-16
DE69415545T2 (de) 1999-09-16
FR2710337A1 (fr) 1995-03-31
DE69415545D1 (de) 1999-02-04

Similar Documents

Publication Publication Date Title
ATE174889T1 (de) Verfahren zur optischen spaltung von antipoden durch kristallisierung
MY129649A (en) Chiral salt resolution
ATE240139T1 (de) Co-kristallisationsprozess
ES8504683A1 (es) Procedimiento de obtencion de un par enantiomerico de isomeros de cihalotrina
FI924668L (fi) Foerfarande foer framstaellning av vaesentligen ren melfalanhydroklorid
BR0316916A (pt) Processo de preparação de formas cristalinas dos enantiÈmeros óticos, formas polimórficas de enantiÈmeros levógiros ou dextrógiros de modafinil, solvatos de dimetilcarbonato e de acetonitrila de enantiÈmeros levógiros ou dextrógiros de modafinil, processo de conversão, processo de preparação de modafinil oticamente ativo, processo de preparação de um dos enantiÈmeros de modafinil, composições farmacêuticas, usos das formas polimórficas do (-)-modafinil ou do (+)-modafinil
DE3586017D1 (de) Stabiles glukose-isomerase-konzentrat und verfahren zu dessen herstellung.
RU2004137681A (ru) Аддукт топирамата и гидрохлорида трамадола и его применения
DK0458386T3 (da) Fremgangsmåde til fremstilling af stabile bitumen-polymerblandinger
DE59405052D1 (de) Verfahren zum herstellen von granulat
DK0759973T3 (da) Fremgangsmåde til klaring af vinase
MX173709B (es) Un metodo para desarrollar cristales de enzimas
DE69707142D1 (de) Verfahren zur herstellung von melamin
DK0727983T3 (da) Fremgangsmåde til fremstilling af et clodronat-præparat
JPS549174A (en) Method of producing seingle crystal
GEP19981257B (en) Method of producing crystalline enantiomeric pair of isomers of (s)-alpha-cyano-3-phenoxybenzyl ester of (1r,cis)-3-(z-3-chlor-3,3,3)-trifluorprop-1-en-1-yl-2,2-dimethylcyclopropionic acid and (r)-alpha-cyano-3-phenoxybenzyl ester of (1s,cis9-3-(z-2-chlor-3,3,3-trifluorprop-1-en-1yl))-2,2-dimethylcyclopropionic acid
DE3060670D1 (en) Process for the separation of the two optical isomers of 1-(o-methoxyphenoxy)-3-isopropylamino-propan-2-ol, optical isomers obtained thereby and pharmaceutical compositions of the levorotatory antipode thereof
DK22885D0 (da) Fremgangsmaade til fremstilling af to enantiomerpar ud fra blandingen af alle 8 stereoisomere af forbindelsen r/s-cyano-3-phenoxy-4-fluorbenzyl-3r/s-(2,2-dichlorvinyl)-2,2-dimethyl-1r/s-cyclopropancarboxylsyrester
US2602047A (en) Method of concentrating isotopic carbon
ATE178051T1 (de) Verfahren zur herstellung einer physikalisch stabilen, kristallinen gamma-modifikation von para-aminobenzolsulfonamid
JPS55115846A (en) Optical resolution of dl-mandelic acid
GB865311A (en) Process for continuous resolution of racemic amino acids
GB1020696A (en) Resolution of a salt of n-benzoyl serine
JPS5228258A (en) Method for growth of crystals from liquid phase
JPS56158792A (en) Preparation of amineborane